Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

Pharma slams Biden waiver support that ‘causes more problems’

Patrick Wingrove
May 13, 2021
Share
adobestock-341417079.jpeg

Five in-house counsel from generic and innovator drug firms say an IP waiver won’t solve the COVID crisis and will likely undermine vaccine confidence

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Tags

IP StrategyUnited StatesNewsPatentsNorth AmericaNorth AmericaJurisdictions
wingrove-patrick-300px.png
Patrick Wingrove
Deputy managing editor Managing IP
Contact
Patrick assists with editorial agenda management, and regularly reports on patent-related issues, including FRAND, supplementary protection certificates and patent eligibility, as well as trade secrets. He also chairs industry events and produces conference newspapers.
more from across site and ros bottom lb

More from across our site

Women in Business Law Awards APAC 2023 Logo
Women in Business Law Awards APAC 2023: open for submissions
The Asia-Pacific awards research cycle has now begun – don’t miss on this opportunity be recognised in 2023
John Harrison, March 21, 2023
SupremeCourtWinCOVER.jpg
Weekly take: SCOTUS should limit Lanham Act reach
The Supreme Court, which is hearing two IP cases this week, should limit the power of US courts to rule on foreign sales
Rani Mehta, March 20, 2023
US capitol map washington dc
Safety first: senators introduce bill to protect standards copyright
Safety standards wouldn’t lose copyright protection when named in law, so long as they were accessible for free online
Rani Mehta, March 17, 2023
TEchAmgenCOVER.jpg
Tech IP counsel wary of overreaching Amgen v Sanofi ruling
In-house tech sources say Amgen v Sanofi has the potential to stifle their prosecution and litigation strategies if SCOTUS’s decision is too broad
Rani Mehta, March 17, 2023
rolls.jpg
This week on MIP: InterDigital v Lenovo ruling, India’s legal market opens
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Max Walters, March 17, 2023
Apple2COVER.jpg
Fed Circuit Apple ruling has little Fintiv impact: counsel
The Federal Circuit said tech firms can challenge the way the USPTO implemented Fintiv, but that won’t mean much for practitioners, say counsel
Rani Mehta, March 16, 2023
Rolls 2k-comp.jpg
Lenovo to pay InterDigital $138.7m for FRAND royalty
The England and Wales High Court handed down one of the most hotly anticipated FRAND rulings for some time
Max Walters, March 16, 2023
Portfolio funding.jpeg
Patent funders remain wary of picking bad apples
Funders discuss different IP portfolio funding options and how they decide whether to offer preferential terms and pricing
Sukanya Sarkar, March 16, 2023
Elephant take-comp.jpg
Weekly take: Milan court is UPC elephant in the room
The issue of the Unified Patent Court’s third central division needs resolving before IP owners can fully embrace Europe’s new era
Max Walters, March 16, 2023
India on map.jpeg
India opens legal market to foreign law firms
Foreign firms and lawyers, including IP practitioners, can now practise in India after years of talk and no action
Sukanya Sarkar, March 15, 2023